Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.

Vaccine. 2009 Aug 20;27(38):5214-9. doi: 10.1016/j.vaccine.2009.06.075. Epub 2009 Jul 9.

PMID:
19596411
2.

A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle.

Hu XD, Yu DH, Chen ST, Li SX, Cai H.

DNA Cell Biol. 2009 Apr;28(4):191-9. doi: 10.1089/dna.2008.0790.

PMID:
19364278
3.

Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.

Pakzad I, Rezaee A, Rasaee MJ, Tabbaraee B, Delpisheh A.

Iran J Immunol. 2009 Mar;6(1):12-21. doi: IJIv6i1A2.

PMID:
19293473
4.

Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.

Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, de Miguel MJ, Marín CM, Barberán M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, Zygmunt MS.

Vaccine. 2009 Mar 10;27(11):1741-9. doi: 10.1016/j.vaccine.2009.01.025. Epub 2009 Jan 30.

PMID:
19186196
5.

Cloning, expression and immunogenicity of the translation initiation factor 3 homologue of Brucella abortus.

González M, Andrews E, Folch H, Sáez D, Cabrera A, Salgado P, Oñate A.

Immunobiology. 2009;214(2):113-20. doi: 10.1016/j.imbio.2008.07.004. Epub 2008 Aug 26.

PMID:
19167989
6.

Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Harms JS, Durward MA, Magnani DM, Splitter GA.

J Immune Based Ther Vaccines. 2009 Jan 6;7:1. doi: 10.1186/1476-8518-7-1.

7.

The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC.

Infect Immun. 2009 Feb;77(2):877-84. doi: 10.1128/IAI.01017-08. Epub 2008 Dec 1.

8.

Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.

Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.

Vaccine. 2009 Jan 7;27(2):187-91. doi: 10.1016/j.vaccine.2008.10.065. Epub 2008 Nov 11.

PMID:
19007836
9.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].

10.

Elimination of Listeria monocytogenes from vacuum-packed dry-cured ham by E-beam radiation.

Hoz L, Cambero MI, Cabeza MC, Herrero AM, Ordónez JA.

J Food Prot. 2008 Oct;71(10):2001-6.

PMID:
18939744
11.

Seroprevalence of brucellosis in yaks (Poephagus grunniens) in India and evaluation of protective immunity to S19 vaccine.

Bandyopadhyay S, Sasmal D, Dutta TK, Ghosh MK, Sarkar M, Sasmal NK, Bhattacharya M.

Trop Anim Health Prod. 2009 Apr;41(4):587-92. doi: 10.1007/s11250-008-9228-0. Epub 2008 Sep 2.

PMID:
18763048
12.

VirB type IV secretory system does not contribute to Brucella suis' avoidance of human dendritic cell maturation.

Billard E, Dornand J, Gross A.

FEMS Immunol Med Microbiol. 2008 Aug;53(3):404-12. doi: 10.1111/j.1574-695X.2008.00441.x. Epub 2008 Jul 9.

13.

Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2.

Fiorentino MA, Campos E, Cravero S, Arese A, Paolicchi F, Campero C, Rossetti O.

Vet Microbiol. 2008 Dec 10;132(3-4):302-11. doi: 10.1016/j.vetmic.2008.05.003. Epub 2008 May 9.

PMID:
18565697
14.

Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes.

Crasta OR, Folkerts O, Fei Z, Mane SP, Evans C, Martino-Catt S, Bricker B, Yu G, Du L, Sobral BW.

PLoS One. 2008 May 14;3(5):e2193. doi: 10.1371/journal.pone.0002193.

15.

Inactivation kinetics of Escherichia coli by pulsed electron beam.

Chalise PR, Hotta E, Matak KE, Jaczynski J.

J Food Sci. 2007 Sep;72(7):M280-5.

PMID:
17995653
16.

Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent.

Pei J, Wu Q, Kahl-McDonagh M, Ficht TA.

Infect Immun. 2008 Jan;76(1):30-7. Epub 2007 Oct 15.

17.

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.

Infect Immun. 2007 Oct;75(10):4923-32. Epub 2007 Jul 30.

18.

Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.

Zhu Bd, Qie Yq, Wang Jl, Zhang Y, Wang Qz, Xu Y, Wang Hh.

Eur J Pharm Biopharm. 2007 Jun;66(3):318-26. Epub 2007 Jan 12.

PMID:
17280823
19.

Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium.

Sangari FJ, Seoane A, Rodríguez MC, Agüero J, García Lobo JM.

Infect Immun. 2007 Feb;75(2):774-80. Epub 2006 Nov 13.

20.

In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

Turkmani A, Ioannidis A, Christidou A, Psaroulaki A, Loukaides F, Tselentis Y.

Ann Clin Microbiol Antimicrob. 2006 Oct 2;5:24.

Items per page

Supplemental Content

Write to the Help Desk